Home World News Favourable Results of Patritumab Deruxtecan in Patients with Leptomeningeal Metastatic Disease of... World News Favourable Results of Patritumab Deruxtecan in Patients with Leptomeningeal Metastatic Disease of Solid Tumours By Ogkologos - July 21, 2025 491 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TUXEDO-3 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR How I Found a Meaningful Career After Cancer October 26, 2020 Tumour Signatures Defined by Next Generation Sequencing Are Linked to Clinical... March 2, 2021 New Research in Treating Metastatic Breast Cancer, Preventing Breast Cancer, and... February 7, 2023 Foodie Fridays-Gazpacho: A Favorite Summer Soup August 6, 2021 Load more HOT NEWS Molecular Burglary: Cancer Cells Hijack Energy from Immune Cells FDA Approves Oral Combination of Decitabine and Cedazuridine for Myelodysplastic Syndromes Wales: 4 in 10 with possible cancer symptoms didn’t contact GP Sen. Amy Klobuchar Announces Breast Cancer Diagnosis, Urges Women Not to...
